- Home
- / Zhejiang CONBA Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Zhejiang CONBA Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥4.7
2024-10-29
Market Capitalization
¥12.1 B
2024-10-29
Revenue
¥6.3 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.9B | 6.6B | 5.8B | 6.0B | 5.9B | 6.6B | 6.3B | 6.3B |
| Cost of goods sold | 1.7B | 1.7B | 2.0B | 2.2B | 2.4B | 2.8B | 3.1B | 3.0B |
| Gross profit | 5.2B | 5.0B | 3.8B | 3.9B | 3.5B | 3.9B | 3.4B | 3.4B |
| Gross profit margin, % | 74.8% | 65.5% | 64.3% | 59.3% | 58.7% | 53.3% | 53.4% | |
| Operating expense total | 3.9B | 3.7B | 2.9B | 2.9B | 2.8B | 2.9B | 2.5B | 2.6B |
| Depreciation and amortization | 243.2M | 1.0B | 366.0M | 351.3M | 1.8M | 330.1M | 342.4M | 364.4M |
| EBITDA | 1.3B | 1.1B | 860.4M | 940.5M | 666.3M | 1.0B | 943.4M | 835.7M |
| EBITDA margin, % | 16.9% | 14.9% | 15.6% | 11.3% | 15.7% | 14.9% | 13.3% | |
| EBIT | 1.2B | 197.2M | 593.7M | (25.0M) | 542.0M | 666.8M | 694.6M | 560.5M |
| EBIT margin, % | 3.0% | 10.3% | -0.4% | 9.2% | 10.2% | 10.9% | 8.9% | |
| Interest income | 22.6M | 25.5M | 21.9M | 14.7M | 55.6M | 53.0M | 35.7M | 17.5M |
| Interest expense | 95.2M | 151.2M | 123.6M | 73.0M | 49.5M | 36.4M | 20.8M | 7.8M |
| Pre tax profit | 1.0B | (50.0M) | 765.6M | 2.5B | 590.0M | 767.7M | 779.9M | 645.2M |
| Income tax expense | 212.7M | 221.5M | 216.4M | 391.1M | 129.9M | 93.0M | 121.6M | 153.6M |
| Net Income | 822.2M | (271.5M) | 549.2M | 2.1B | 460.1M | 674.7M | 658.4M | 491.6M |